Zelong Feng

No ORCID on file · 1 paper in corpus
review 2022
Frontiers in oncology ·doi:10.3389/fonc.2022.917439

Human epidermal growth factor receptor 2 (HER2) is a highly expressed tumor marker in epithelial ovarian cancer, and its overexpression is considered to be a potential factor of poor prognosis. Therefore, monitoring the expression of HER2 r…